either rocket to the moon or crash like an astroid hitting earth. Now, I can think of at least 10 bio techs that have launched from penny status to $6 and higher over the past 24 months. I've owned three of them that have now put me in a tax bracket I don't care to be in when u account for total income. What Zalicus is engaged in looks very promising hence my reasons for being long and for also thinking they will do the same. People forget that although they are a research and development stage company, they actually have revenues and agreements happening right now, and with some huge heavy weight names as well. The fact that their pipeline looks the way it does can only validate my conviction list of companies that are true and promising in their early stages. But of course it is a spec buy and we should realize that going in. There is sooooooooo much psychology playing into the ownership of their shares that a real investor will simply take this with a grain of salt. Cheers!